ࡱ> XZW bjbj 6& .....$'.'.'.Pw.4.<'.=X.....000C=E=E=E=E=E=E=$@Bi=.100"11i=....~=~4~4~41|....C=~41C=~4~4+;0<.`{3 '.P2[<"/==0=}<"D2$DD<D.<0>0,~41$31000i=i=4v000=1111D000000000 ,: For New and Renewal Applications (PHS 398) DO NOT SUBMIT UNLESS REQUESTED For Non-competing Progress Reports (PHS 2590) Submit only Active Support for Key PersonnelPHS 398/2590 OTHER SUPPORT Provide active support for all key personnel. Other Support includes all financial resources, whether Federal, non-Federal, commercial or institutional, available in direct support of an individual's research endeavors, including but not limited to research grants, cooperative agreements, contracts, and/or institutional awards. Training awards, prizes, or gifts do not need to be included. There is no "form page" for other support. Information on other support should be provided in the format shown below, using continuation pages as necessary. Include the principal investigator's name at the top and number consecutively with the rest of the application. The sample below is intended to provide guidance regarding the type and extent of information requested. For instructions and information pertaining to the use of and policy for other support, see Other Support in the PHS 398 Part III, Policies, Assurances, Definitions, and Other Information. Note effort devoted to projects must now be measured using person months. Indicate calendar, academic, and/or summer months associated with each project. Format NAME OF INDIVIDUAL ACTIVE/PENDING Project Number (Principal Investigator) Source Title of Project (or Subproject) The major goals of this project areDates of Approved/Proposed Project Annual Direct Costs Person Months (Cal/Academic/ Summer)OVERLAP (summarized for each individual)Samples ANDERSON, R.R. ACTIVE 2 R01 HL 00000-13 (Anderson) 3/1/1997 2/28/2002 3.60 calendar NIH/NHLBI $186,529 Chloride and Sodium Transport in Airway Epithelial Cells The major goals of this project are to define the biochemistry of chloride and sodium transport in airway epithelial cells and clone the gene(s) involved in transport. 5 R01 HL 00000-07 (Baker) 4/1/1994 3/31/2002 1.20 calendar NIH/NHLBI $122,717 Ion Transport in Lungs The major goal of this project is to study chloride and sodium transport in normal and diseased lungs. R000 (Anderson) 9/1/1996 8/31/2002 1.20 calendar Cystic Fibrosis Foundation $43,123 Gene Transfer of CFTR to the Airway Epithelium The major goals of this project are to identify and isolate airway epithelium progenitor cells and express human CFTR in airway epithelial cells. PENDING DCB 950000 (Anderson) 12/01/2002 11/30/2004 2.40 calendar National Science Foundation $82,163 Liposome Membrane Composition and Function The major goals of this project are to define biochemical properties of liposome membrane components and maximize liposome uptake into cells. OVERLAP There is scientific overlap between aim 2 of NSF DCB 950000 and aim 4 of the application under consideration. If both are funded, the budgets will be adjusted appropriately in conjunction with agency staff. RICHARDS, L. NONE HERNANDEZ, M. ACTIVE 5 R01 CA 00000-07 (Hernandez) 4/1/1995 3/31/2002 3.60 academic NIH/NCI $110,532 Gene Therapy for Small Cell Lung Carcinoma The major goals of this project are to use viral strategies to express the normal p53 gene in human SCLC cell lines and to study the effect on growth and invasiveness of the lines. 5 P01 CA 00000-03 (Chen) 7/1/2000 6/30/2002 1.80 academic NIH/NCI $104,428 (sub only) 3.00 summer Mutations in p53 in Progression of Small Cell Lung Carcinoma The major goals of this subproject are to define the p53 mutations in SCLC and their contribution to tumor progression and metastasis. BE 00000 (Hernandez) 9/1/1996 8/31/2002 1.80 academic American Cancer Society $86,732 p53 Mutations in Breast Cancer The major goals of this project are to define the spectrum of p53 mutations in human breast cancer samples and correlate the results with clinical outcome. OVERLAP Potential commitment overlap for Dr. Hernandez between 5 R01 CA 00000-07 and the application under consideration. If the application under consideration is funded with Dr. Hernandez committed at 3.60 person months, Dr. Hernandez will request approval to reduce her months on the NCI grant. BENNETT, P. ACTIVE Investigator Award (Bennett) 9/1/1999 8/31/2002 9.00 calendar Howard Hughes Medical Institute $581,317 Gene Cloning and Targeting for Neurological Disease Genes This award supports the PIs program to map and clone the gene(s) implicated in the development of Alzheimers disease and to target expression of the cloned gene(s) to relevant cells. OVERLAP: None     Program Director/Principal Investigator: (Last, first, middle)  PHS 398/2590 (Rev. 06/09) Page ___ Other Support Format Page  -L \ # ! k]]OOAhPCJOJQJ^JaJh/cCJOJQJ^JaJh>GCJOJQJ^JaJ&h+56CJOJQJ\]^JaJ h+6CJOJQJ]^JaJ h+5CJOJQJ\^JaJh+CJOJQJ^JaJh8CJOJQJ^JaJhy5CJ\aJhyhyCJ\aJh+CJOJQJ^JaJhyh+CJaJh%CJaJhyhyCJaJLO P ! ( }}}}}x$a$H$2kdi$$Ifl*+4 la $Ifgdy4kd$$Ifl*+4 la $$Ifa$gdy ! ( ) < B C L M   ̿}l[Jl[l;hCJOJQJ^JaJy( h8hLCJOJQJ^JaJ h8h"yCJOJQJ^JaJ h8hJjCJOJQJ^JaJ h8hLCJOJQJ^JaJ&h8h+6CJOJQJ]^JaJ h8h+CJOJQJ^JaJh+CJOJQJaJh+>*CJOJQJaJh+5CJOJQJ\aJ&h8hP5CJ OJQJ\^JaJ h+5CJOJQJ\^JaJ( ) < L M v } !:kd$$Ifl4*+4 laf4$If$a$ !"*JKLTUdkñ{gUD3 h8hLCJOJQJ^JaJ h8h+CJOJQJ^JaJ#h8h+>*CJOJQJ^JaJ&h8h+5CJOJQJ\^JaJ h+5CJOJQJ\^JaJ h8h+CJOJQJ^JaJ&h8h+6CJOJQJ]^JaJ#h8h+>*CJOJQJ^JaJh+CJOJQJaJhLh+CJOJQJaJ h8hJjCJOJQJ^JaJ h8hLCJOJQJ^JaJ!"KLTUdk]XVVVL hh`h$a$:kd$$Ifl4*+4 laf4$If`kd9$$Ifl4Fd(#*t    4 laf4JK޻ޭޠ}nZZD+h8h+>*CJOJQJ^JaJmHsH&h8h+5CJOJQJ\^JaJh8>*CJOJQJ^JaJ#h8h8>*CJOJQJ^JaJ h8h8CJOJQJ^JaJh8h+OJQJ^JhCJOJQJ^JaJ#h8h+>*CJOJQJ^JaJ h8hLCJOJQJ^JaJ h8h+CJOJQJ^JaJ h8hy@CJOJQJ^JaJJKh^hgd8 hh`hh^hh`h!8cd\QRq`h^hh`h hh`hd(78NRrz=O$%볢|k]UhPOJQJhCJOJQJ^JaJ h8h"yCJOJQJ^JaJ&h8h+5CJOJQJ\^JaJ#h8h+>*CJOJQJ^JaJ h8hLCJOJQJ^JaJ h8h+CJOJQJ^JaJ"h+]CJOJQJ^JaJmHsH(h8hLCJOJQJ^JaJmHsH(h8h+CJOJQJ^JaJmHsHqrz"\$%&()+,./12byz"@ `@ " 0*dh`hh^h%&')*,-/023Y[abxyz{|ܿܯugV hJj5CJOJQJ\^JaJhJjCJOJQJ^JaJhe<CJOJQJ^JaJh+wCJOJQJ^JaJhJjCJ^JaJjhJjCJUmHnHuhJjhJjCJaJhJjCJaJhJj>*CJOJQJ^JaJh%CJOJQJ^JaJhJjCJOJQJ^JaJh62jh62Uh+CJ^JaJ!z 0* " V!gdP d0*B 00P&P:p8/ =!"#$% Dp9 0P&P/ =!"#$% Dpg$$If!vh5+#v+:V l5+/ /  4c$$If!vh5+#v+:V l5+/  / 4i$$If!vh5+#v+:V l45+/ /  4f4$$If!vh555t#v#v#vt:V l4555t/ / / / / / / 4f4i$$If!vh5+#v+:V l45+/ / 4f4^e 2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH N`N Normal7$8$ CJOJQJ_HaJmH sH tH T@T  Heading 1$$@&a$5CJOJQJ\^JaJTT  Heading 2$<@&56OJQJ\]^JHH  Heading 3$<@& OJQJ^JNN  Heading 4$<@&5OJQJ\^JFF  Heading 5 <@& CJ^JaJLL  Heading 6 <@&6CJ]^JaJNN  Heading 7 <@&CJOJQJ^JaJTT  Heading 8 <@&6CJOJQJ]^JaJZ Z  Heading 9 <@& 56CJOJQJ\]^JaJDA D Default Paragraph FontVi@V  Table Normal :V 44 la (k (No List checkboxL$$d%d&d'dNOPQa$ B*CJ^JaJmHnHphuHTH Block Textx]^^J6B6 Body Textx^JPC"P Body Text IndentCJOJQJ^JaJBQ2B Body Text 3x CJ^JaJPMBP Body Text First Indent `tN!Rt Body Text First Indent 2hx^h`CJOJQJ^JaJVR@bV Body Text Indent 2hdx^h^JXSrX Body Text Indent 3hx^h CJ^JaJ<"< Caption xx 5\^J6?6 Closing ^^J@@@  Comment Text CJ^JaJ(L( Date^JRYR  Document Map-D M OJQJ^J@+@  Endnote Text CJ^JaJh$h Envelope Address!@ &+D/^@ OJQJ^JN%N Envelope ReturnCJOJQJ^JaJ8 @8 Footer !^JBB  Footnote Text! CJ^JaJ8@"8 Header " !^J> > Index 1#^`^J> > Index 2$^`^J> > Index 3%^`^J> > Index 4&^`^J>> Index 5'^`^J>> Index 6(^`^J>> Index 7)^`^J>> Index 8*^`^J>> Index 9+p^p`^JH!2H  Index Heading,5OJQJ\^J8/8 List-h^h`^J<2< List 2.^`^J<3< List 3/8^8`^J<4< List 40^`^J<5< List 51^`^J>0"> List Bullet 2 & F^JB62B List Bullet 2 3 & F^JB7BB List Bullet 3 4 & F^JB8RB List Bullet 4 5 & F^JB9bB List Bullet 5 6 & F^JFDrF List Continue7hx^h^JJEJ List Continue 28x^^JJFJ List Continue 398x^8^JJGJ List Continue 4:x^^JJHJ List Continue 5;x^^J>1> List Number < & F^JB:B List Number 2 = & F^JB;B List Number 3 > & F^JB<B List Number 4 ? & F ^JB=B List Number 5 @ & F ^Jr- r  Macro Text(A  ` @ 7$8$OJQJ^J_HmH sH tH I" Message HeadergB8$d%d&d'd-DM NOPQ^8` OJQJ^JB2B Normal Indent C^^J8O8 Note HeadingD^JDZRD Plain TextECJOJQJ^JaJ4K4 SalutationF^J:@r: Signature G^^JFJF SubtitleH$<@&a$ OJQJ^JX,X Table of AuthoritiesI^`^JP#P Table of FiguresJ ^` ^JV>V TitleK$<@&a$5CJ KHOJQJ\^JaJ H.H  TOA HeadingLx5OJQJ\^J** TOC 1M^J22 TOC 2 N^^J22 TOC 3 O^^J22 TOC 4 P^^J22 TOC 5 Q^^J22 TOC 6 R^^J22 TOC 7 S^^J22 TOC 8 T^^J22 TOC 9 U^^J@a@ Subhead in Paragraph@[r@ E-mail SignatureW^J>`> HTML AddressX 6]^JReR HTML PreformattedYCJOJQJ^JaJ8^8 Normal (Web)Z^JHH H6[d1$@&G$5CJOJQJ\^JaJh/h Title 2 - Small\$7$8$a$"5OJQJ\^J_HmH sH tH B'B Comment ReferenceCJaJ:: Quick A. ^ & F1$^JVV sbirtop)_ & F 0d^`0^Jxx Reminder List 1` & F hdx#5B*CJOJQJ\^JaJph|| Reminder List 2%a & F hd<^B*CJOJQJ^JaJphl"l Reminder List 3b & F h88<^8CJOJQJ^JaJ6U16 Hyperlink >*B*phHBH Jj Balloon TextdCJOJQJ^JaJPK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] % 6 D6 TT! %( !qz@  @ (  \B  C D#" ?0(  B S  ?T5+u$RRRR~~8*urn:schemas-microsoft-com:office:smarttagsCity9*urn:schemas-microsoft-com:office:smarttagsplace    ( 0 7 &&(())+,./12 ! 7 &&(())+,./1233!) "k ! 8 %&&(())+,./123cz%&&(())+,./12|.9}T~b|#Ҁp0qjgB4y|`aa3(ʮ`T`3rb'pNx^^`.^`.88^8`.^`.^`OJQJ^Jo(^`OJQJ^Jo(88^8`OJQJ^Jo(^`OJQJ^Jo(hh^h`.hh^h`OJQJ^Jo(hh^h`OJQJ^Jo(hh^h`OJQJ^Jo(rhh^h`B*OJQJ^Jo(ph @0^`0.@0^`0.@p0^p`0.@@ 0^@ `0.@0^`0.@0^`0.@0^`0.@0^`0.@P0^P`0~}|ya3(T`'p/cy@+w@>L+R/J06235e<?.YF~7OX+]Jj0v"y{P>G8(%y2= &(@ X@Unknown G* Times New Roman5Symbol3. * Arial3* Times5. *aTahoma?= * Courier New;. * HelveticayMonotype SortsWP MultinationalB CourierA BCambria Math"h)F)F1+fq  q !xx4d2QHX?y2!xx'PHS 398/2590, Other Support Format PageDDHHS, Public Health Service Grant Application, Grant Progress ReportUPHS Grant Application, Grant Progress Report, PHS 398/2590, Other Support Format PageOffice of Extramural Programs Leslie DormanD         Oh+'0\ H    $ 0<DLT(PHS 398/2590, Other Support Format PageHDHHS, Public Health Service Grant Application, Grant Progress Report Office of Extramural ProgramsXPHS Grant Application, Grant Progress Report, PHS 398/2590, Other Support Format Page Normal.dotm Leslie Dorman2Microsoft Office Word@F#@ Y@Un3 @Un3 q՜.+,D՜.+,` hp  DHHS/PHS/NIH   (PHS 398/2590, Other Support Format Page Title`@0T_AdHocReviewCycleID_EmailSubject _AuthorEmail_AuthorEmailDisplayName_ReviewingToolsShownOnceI0Some Final Edits to the PHS398 & SF424 (R&R)HahnM@OD.NIH.GOVHahn, Marcia (NIH/OD) [E]  !"#%&'()*+,-./0123456789:;<=>?@ABCDEFHIJKLMNPQRSTUVYRoot Entry F`{3 [Data 1Table$EWordDocument6SummaryInformation(GDocumentSummaryInformation8OCompObjy  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q